Halozyme Therapeutics (HALO) Stock Price & Financial Analysis
Halozyme Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Halozyme Therapeutics
What is the current stock price for HALO?
As of the latest trading session, HALO stock trades at $68.98. The 52-week range is $47.50–$82.22, with a day range of $67.83–$69.74.
What is the P/E ratio for HALO?
Halozyme Therapeutics's trailing P/E ratio is 26.9, meaning investors pay $26.9 for every $1 of annual earnings. The forward P/E is 37.4, reflecting analyst expectations for future earnings. Halozyme Therapeutics operates in the Healthcare sector.
Does HALO pay dividends?
Halozyme Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for HALO?
Based on 1 analyst, the consensus for HALO is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of HALO?
Halozyme Therapeutics's market capitalization is $8.55B, classifying it as a mid-cap company. Halozyme Therapeutics operates in the Healthcare sector within the Biotechnology industry.